Skip to Main Content

Paper Details

Intermediate-Dose versus Standard-Dose Prophylactic Anticoagulation in Patients with COVID-19 Admitted to the Intensive Care Unit: 90-Day Results from the INSPIRATION Randomized Trial.
Thromb Haemost
56
2022
COVID-19, Patients, Thrombotic complications, arterial thrombosis, cRitically, coronavirus disease 2019, pATIents, patients, venous or arterial thrombosis, women
Author NameAffiliation
Aakriti GuptaYale/YNHH Center for Outcomes Research and Evaluation
Aakriti GuptaCardiovascular Research Foundation
Aakriti GuptaColumbia University Irving Medical Center/NewYork-Presbyterian Hospital
Harlan M KrumholzYale/YNHH Center for Outcomes Research and Evaluation
Harlan M KrumholzYale School of Medicine
Harlan M KrumholzYale School of Public Health
Harlan M KrumholzYale/YNHH Center for Outcomes Research and Evaluation
Harlan M KrumholzYale School of Medicine
Harlan M KrumholzYale School of Public Health
  • 1 - 9

Datasets

Release 1.2